5 Biopharmas With Upcoming Catalysts That Should Rally [Antares Pharma Inc] - Seeking Alpha

5 Biopharmas With Upcoming Catalysts That Should Rally [Antares Pharma Inc] - Seeking Alpha

Halozyme 60 Minute, 10 Day Chart Analysis As Of Close, 9/16/13 - Sentime...

Solta Medical Inc (SLTM): Strong Acquisition Target Solta Poised To Challenge In Fat Loss And Skin Care Markets - Seeking Alpha

Solta Medical Inc (SLTM): Strong Acquisition Target Solta Poised To Challenge In Fat Loss And Skin Care Markets - Seeking Alpha

Solta Medical Inc (SLTM): Voce Capital Pushes For Acquisition Of Solta Medical, Activist Investor David Callan Joins In - Seeking Alpha

Solta Medical Inc (SLTM): Voce Capital Pushes For Acquisition Of Solta Medical, Activist Investor David Callan Joins In - Seeking Alpha

Tetraphase Pharmaceuticals Inc (TTPH): Trius Acquired Last Week, Tetraphase Could Be Next - Seeking Alpha

Tetraphase Pharmaceuticals Inc (TTPH): Trius Acquired Last Week, Tetraphase Could Be Next - Seeking Alpha

3 Near-Term Catalysts Could Double Onoconova's Valuation [Array Biopharma Inc] - Seeking Alpha

3 Near-Term Catalysts Could Double Onoconova's Valuation [Array Biopharma Inc] - Seeking Alpha

Biodel Inc (BIOD): BioPharma Catalyst Trade Pick Of The Week: Biodel | Mentions: Astex Pharmaceuticals, Inc. (ASTX), Eli Lilly & Co. (LLY), MannKind Corporation (MNKD) - Seeking Alpha

Biodel Inc (BIOD): BioPharma Catalyst Trade Pick Of The Week: Biodel | Mentions: Astex Pharmaceuticals, Inc. (ASTX), Eli Lilly & Co. (LLY), MannKind Corporation (MNKD) - Seeking Alpha

Video Chart Analysis and Commentary on Trius Therapeutics ($TSRX)

Video Chart Analysis and Commentary on Trius Therapeutics ($TSRX)

Updated:Trade Call Opinion: $TSRX For a Bounce Back Over $8

Updated:Trade Call Opinion: $TSRX For a Bounce Back Over $8

BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market - Seeking Alpha

BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market - Seeking Alpha

I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.

I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.

GTx Pharma Showing Bullish Chart Before Upcoming June Catalyst Data Release

GTx Pharma Showing Bullish Chart Before Upcoming June Catalyst Data Release

I bought Antares @ $3.95, I see a move to $4.35 short term

I bought Antares @ $3.95, I see a move to $4.35 short term

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed -- Trefis

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed -- Trefis

Insmed: Top-Line Data Should Rally Stock | Investing.com

Insmed: Top-Line Data Should Rally Stock | Investing.com

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed - Seeking Alpha

Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed - Seeking Alpha

Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy - Seeking Alpha

Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy - Seeking Alpha

GTx pursues three drug studies; shares rise - Proactiveinvestors (NA)

GTx pursues three drug studies; shares rise - Proactiveinvestors (NA)

Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion - Seeking Alpha

Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion - Seeking Alpha

Biotechs In The Age Of Terror | Investing.com

Biotechs In The Age Of Terror | Investing.com